公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial | JYH-MING LIOU ; Bair M.-J.; CHIEH-CHANG CHEN ; YI-CHIA LEE ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Tseng C.-H.; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU | American Journal of Gastroenterology | 40 | 38 | |
2019 | Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang, C.-M.; YU-JEN FANG ; Bair, M.-J.; Chen, P.-Y.; Chang, C.-Y.; Hsu, Y.-C.; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Lee, J.-Y.; Yang, T.-H.; Luo, J.-C.; Chen, C.-Y.; WEN-FENG HSU ; YEN-NIEN CHEN ; Wu, J.-Y.; Lin, J.-T.; TZU-PIN LU ; Chuang, E.Y.; El-Omar, E.M.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease; ERIC YAO-YU CHUANG | The Lancet Infectious Diseases | 125 | 111 | |
2020 | Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan | Yang T.-H.; YU-JEN FANG ; SHIH-JER HSU ; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; CHIEN-HUNG CHEN | Open Forum Infectious Diseases | 24 | 25 | |
2023 | Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials | MEI-JYH CHEN ; Chen, Po-Yueh; YU-JEN FANG ; Bair, Ming-Jong; CHIEH-CHANG CHEN ; CHIEN-CHUAN CHEN ; Yang, Tsung-Hua; Lee, Ji-Yuh; Yu, Chien-Chun; Kuo, Chia-Chi; Chiu, Min-Chin; Chou, Chu-Kuang; Chen, Chi-Yi; Hu, Wen-Hao; Tsai, Min-Horn; Hsu, Yao-Chun; CHIA-TUNG SHUN ; Luo, Jiing-Chyuan; JAW-TOWN LIN ; El-Omar, Emad M; MING-SHIANG WU ; JYH-MING LIOU | The lancet. Gastroenterology & hepatology | 9 | 5 | |
2019 | Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis | CHEN-HUA LIU ; Shih Y.-L; Yang S.-S; Lin C.-L; YU-JEN FANG ; Cheng P.-N; Chen C.-Y; Peng C.-Y; Hsieh T.-Y; Chiu Y.-C; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 7 | 7 | |
2012 | Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma | SHIH-HUNG YANG ; Lin L.-W.; YU-JEN FANG ; ANN-LII CHENG ; SUNG-HSIN KUO | Annals of Hematology | 6 | 2 | |
2024 | Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis | TZU-CHAN HONG ; El-Omar, Emad M; YU-TING KUO ; Wu, Jeng-Yih; MEI-JYH CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Leow, Alex Hwong Ruey; Lu, Hong; JAW-TOWN LIN ; YU-KANG TU ; Yamaoka, Yoshio; MING-SHIANG WU ; JYH-MING LIOU | The lancet. Gastroenterology & hepatology | 2 | | |
2015 | The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study | JYH-MING LIOU ; Chang C.-Y.; MEI-JYH CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; HSIU-PO WANG ; Sheu B.-S.; Lin J.-T.; Bair M.-J.; MING-SHIANG WU ; Tai C.-M.; Lee C.-T.; Wang W.-L.; YI-CHIA LEE ; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | PLoS ONE | 65 | 63 | |
2012 | Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers | CHIEN-CHUAN CHEN ; Lee J.-Y.; YU-JEN FANG ; SHIH-JER HSU ; MING-LUN HAN ; PING-HUEI TSENG ; JYH-MING LIOU ; Hu F.-C.; Lin T.-L.; MING-SHIANG WU ; HSIU-PO WANG ; Lin J.-T. | Alimentary Pharmacology and Therapeutics | 30 | 27 | |
2022 | Randomized controlled trial of early endoscopy for upper gastrointestinal bleeding in acute coronary syndrome patients | Chung, Chen-Shuan; CHIEH-CHANG CHEN ; Chen, Kuan-Chih; YU-JEN FANG ; WEN-FENG HSU ; YEN-NIEN CHEN ; Tseng, Wei-Chuang; Lin, Cheng-Kuan; Lee, Tzong-Hsi; HSIU-PO WANG ; YEN-WEN WU | Scientific reports | 2 | 1 | |
2008 | A rare diagnosis of right upper quadrant abdominal pain | Chung C.-S.; HSIU-PO WANG ; YU-JEN FANG ; REY-HENG HU ; Hsiao J.-K.; Chen C.-G.H. | Gut | 0 | 0 | |
2019 | Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C | SHIH-JER HSU ; Chiu M.-C.; YU-JEN FANG ; Yang T.-H.; Yu J.-J.; CHIEH-CHANG CHEN ; Kuo C.-C.; Lee J.-Y.; CHIEN-HUNG CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 19 | 16 | |
2023 | Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial | JYH-MING LIOU ; Jiang, Xiao-Tao; CHIEH-CHANG CHEN ; Luo, Jiing-Chyuan; Bair, Ming-Jong; Chen, Po-Yueh; Chou, Chu-Kuang; YU-JEN FANG ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Lee, Ji-Yuh; Yang, Tsung-Hua; Yu, Chien-Chun; Kuo, Chia-Chi; Chiu, Min-Chin; Chen, Chi-Yi; CHIA-TUNG SHUN ; Hu, Wen-Hao; Tsai, Min-Horn; Hsu, Yao-Chun; Tseng, Cheng-Hao; Chang, Chi-Yang; JAW-TOWN LIN ; El-Omar, Emad M; MING-SHIANG WU ; Wu, Chun-Ying; Lee, Yi-Chia; PING-HUEI TSENG ; Wu, Jeng-Yih; Tai, Chi-Ming; Lee, Ching-Tai; Wang, Wen-Lun | The lancet. Gastroenterology & hepatology | 11 | 6 | |
2016 | Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; CHIA-TUNG SHUN ; Lin J.-T.; YI-CHIA LEE ; MING-SHIANG WU ; the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gut | 62 | 59 | |
2013 | Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Chang, Chi-Yang; YU-JEN FANG ; Lee, Ji-Yuh; SHIH-JER HSU ; Luo, Jiing-Chyuan; Chang, Wen-Hsiung; Hsu, Yao-Chun; Tseng, Cheng-Hao; PING-HUEI TSENG ; HSIU-PO WANG ; Yang, Ueng-Cheng; CHIA-TUNG SHUN ; Lin, Jaw-Town; YI-CHIA LEE ; MING-SHIANG WU | LANCET | 219 | 196 | |
2021 | Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan | CHEN-HUA LIU ; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU ; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG ; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; CHIEN-CHING HUNG ; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T. Y.; JIA-HORNG KAO | Hepatology International | 14 | 14 | |
2021 | Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU ; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG ; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO | Clinical and Molecular Hepatology | 8 | 8 | |
2020 | Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU ; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG ; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; JIA-HORNG KAO | Gut | 26 | 27 | |
2023 | Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan | CHEN-HUA LIU ; Peng, Cheng-Yuan; CHUN-JEN LIU ; Chen, Chi-Yi; Lo, Ching-Chu; Tseng, Kuo-Chih; Su, Pei-Yuan; Kao, Wei-Yu; Tsai, Ming-Chang; Tung, Hung-Da; Cheng, Hao-Tsai; Lee, Fu-Jen; Huang, Chia-Sheng; Huang, Ke-Jhang; Shih, Yu-Lueng; Yang, Sheng-Shun; Wu, Jo-Hsuan; Lai, Hsueh-Chou; YU-JEN FANG ; Chen, Po-Yueh; Hwang, Jow-Jyh; Tseng, Chi-Wei; Su, Wei-Wen; Chang, Chun-Chao; Lee, Pei-Lun; Chen, Jyh-Jou; Chang, Chi-Yang; Hsieh, Tsai-Yuan; Chang, Chung-Hsin; Huang, Yi-Jie; JIA-HORNG KAO | Hepatology international | 5 | 4 | |
2023 | Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection | CHEN-HUA LIU ; YU-JEN FANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; SHANG-CHIN HUANG ; TAI-CHUNG TSENG ; Wu, Jo-Hsuan; PEI-JER CHEN ; JIA-HORNG KAO | Journal of clinical medicine | 0 | 0 | |